Endogenex
endogenex.com
Actively hiring
Health Care
As featured in
Follow
Overview
News
Salaries
Products
People
Growth
Offices
Financials
Funding and backers
Total raised
$121.9M
6 rounds on record
Latest round
$69.6M
Venture round · Jun 2024 · 2 yr ago
Team
22
US Form 5500 (plan participants) · Dec 2025 · +5% in a year
Backers
3
Arboretum Ventures, Longitude Capital
The money's age
Long since its last round
27 months since the last round · not hiring
Momentum
0/100
no fresh signals
Last sign of life
this month
a posting or a news item
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Jan 14, 2025
New executive Endogenex Appoints Krissy Wright as Chief Financial Officer · PRNewswire
Jun 13, 2024
Raised a round Venture round $69.6M · SEC Form D
Oct 11, 2023
Raised a round Venture round $18.3M · SEC Form D
May 18, 2023
New executive Endogenex Appoints Christopher Sorli as Chief Medical Officer · PRNewswire
Feb 17, 2023
Raised a round Venture round $9.2M · SEC Form D
Apr 15, 2021
Raised a round Venture round $12M · SEC Form D
Nov 30, 2018
Raised a round Venture round $12.8M · SEC Form D
Jan 31, 2018
Took on debt financing $140k · SEC Form D
2017
Founded
Funding rounds
| Round | Date | Amount | Investors | Source |
|---|---|---|---|---|
| Venture round | Jun 2024 | $69.6M | — | SEC Form D |
| Venture round | Oct 2023 | $18.3M | — | SEC Form D |
| Venture round | Feb 2023 | $9.2M | — | SEC Form D |
| Venture round | Apr 2021 | $12M | — | SEC Form D |
| Venture round | Nov 2018 | $12.8M | — | SEC Form D |
| Debt Financing | Jan 2018 | $140k | — | SEC Form D |
Registers and programsofficial lists and records that name the company
| Legal entity | Endogenex, Inc. | SEC Form D |
Founders and leadersfrom filings, registers and the company's site
Stacey PughExecutive Officer, DirectorSEC Form D
John DeedrickDirectorSEC Form D
Paul HindrichsExecutive Officer, DirectorSEC Form D
Robert KukuljanExecutive OfficerSEC Form D
Michael BrenzelExecutive OfficerSEC Form D
Robert KukujlanExecutive OfficerSEC Form D
Backed byfrom the funds' portfolios and accelerator catalogs
Arboretum Ventures 
Longitude Capital 
Lumira Ventures Similar startupsby what they do, their industry and backers
WovenX optimizes access to specialty GI care, driving better outcomes for patients, providers and healthcare organizations.
Now Enrolling: Clinical Trial for Type 1 Diabetes. See If You Qualify.
Anumana develops artificial intelligence electrocardiogram algorithms that detect hidden cardiac disease. Its models find conditions…
Alife is building technology for both clinics and patients.
At cellvie, we are pioneering Therapeutic Mitochondria Transplantation, a novel treatment approach aimed at the cellular energy metabolism.
Foundation models for radiology practices and healthcare systems.
News
UPDATE: Endogenex Announces Full Enrollment of the ReCET Clinical Study
350 Patients Enrolled Across Sites in the United States and Australia, Advancing the Path to FDA Approval of a Novel Endoscopic Treatment for Type 2 Diabetes
Read more
Report
UPDATE: Endogenex Announces Full Enrollment of the ReCET Clinical Study
350 Patients Enrolled Across Sites in the United States and Australia, Advancing the Path to FDA Approval of a Novel Endoscopic Treatment for Type 2 Diabetes MINNEAPOLIS, July 08, 2026 (GLOBE NEWSWIRE) - Endogenex, a clinical-stage medical device company
Read more
Report
Endogenex Announces Full Enrollment of the ReCET Clinical Study
350 Patients Enrolled Across Sites in the United States and Australia, Advancing the Path to FDA Approval of a Novel Endoscopic Treatment for Type 2 Diabetes
Read more
Report
Report
Endogenex: $50 Million Raised For Type 2 Diabetes Treatment Technology
Endogenex, a clinical-stage medical technology company, has closed a $50 million Series C extension to support its ongoing clinical development and regulatory efforts, as detailed in its official announcement.The financing round was led by Arboretum Ventu
Read more
Report
Pro access
Upgrade to see all 20 mentions
Upgrade to a paid plan to read every media mention of this company - funding news, awards, product launches and press releases from all the outlets writing about it.
Every media mention and press release
Funding news, awards and product launches
Fresh coverage from every outlet writing about the company
Upgrade now
Cancel anytime. Secure checkout. Instant activation.
People
Stacey Pugh
Executive Officer, Director
John Deedrick
Director
Paul Hindrichs
Executive Officer, Director
Robert Kukuljan
Executive Officer
Michael Brenzel
Executive Officer
Robert Kukujlan
Executive Officer
Juliet Bakker
Director
James Eadie M.D.
Director
Gerald Brunk
Director
Jeffrey Terrell
Director
James Eadie
Director
Names and roles come from public filings, company registers and the company's own site. Is this you? Correct or remove · How we handle this data
Offices
Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
Plymouth
United States
HQ
Contact Us
200-500 est. staff
Financials
Total raised
$122M
Latest round
Venture - Series Unknown
Funding rounds
6